Life Science Disruptors →
Director, Life Sciences Institute, University of Michigan
VP of Research & Policy, Ewing Marion Kauffman Foundation
Chairman, CEO, & Founder, Alexandria Real Estate Equities
Executive Partner, Sofinnova Ventures
Partner at New Enterprise Associates
Co-Founder and CEO, Wetpaint
VP of Research and Special Initiatives, Google
September 26, 2017 ·
September 28, 2017 ·
Cambridge, MA-based Idenix Pharmaceuticals, a maker of hep C drugs, was acquired by Merck in June 2014.
From Our Editors · Podcast
Mary Lou Jepsen is a fearsome samurai when it comes to the design and manufacturing of electronics.
Xconomy Insight · Special Report
Success or failure depends on you. Get advice from the experts to help your startup succeed
137 companies raise more than $276 million in 2016
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2017, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.